我们的网站为什么显示成这样?

可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:

|本期目录/Table of Contents|

血管钠肽抑制内质网应激减轻糖尿病大鼠缺血/再灌注心肌损伤

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2016年第6期
页码:
651-655
栏目:
基础研究
出版日期:
2016-07-05

文章信息/Info

Title:
Vasonatrin peptide inhibits endoplasmic reticulum stress and attenuates myocardial ischemia/reperfusion injury in diabetic rats
作者:
梁向艳1铁 茹1苏菲菲2于 军3朱妙章1张海锋1
(第四军医大学:1.教学实验中心,陕西 西安 710032,2.唐都医院心血管内科,陕西 西安 710038,4.生理学教研室,陕西 西安 710032;3.西安医学院第二附属医院中心实验室,陕西 西安 710004)
Author(s):
LIANG Xiang-yan1 TIE Ru1 SU Fei-fei2 YU Jun3 ZHU Miao-zhang4 ZHANG Hai-feng1
(1.Experimental Teaching Centre, 4.Department of Physiology, Fourth Military Medical University, Xi’an 710032, Shaanxi, China;
2.Department of Cardiology, Tangdu Hospital, Fourth Military Medical University, Xi’an 710038, Shaanxi, China;
3.Central Laboratory, Second Affiliated Hospital, Xi’an Medical University, Xi’an 710004, Shaanxi, China)
关键词:
血管钠肽心肌缺血/再灌注损伤内质网应激PKG糖尿病
Keywords:
vasonatrin peptide myocardial ischemia/reperfusion injury endoplasmic reticulum stress PKG diabetes
分类号:
R514
DOI:
-
文献标识码:
A
摘要:
目的 观察人工合成的钠尿肽——血管钠肽(VNP)对糖尿病(DM)大鼠心肌缺血/再灌注(MI/R)损伤的影响及机制。方法 高脂饲料喂养SD大鼠4周后,注射链脲霉素STZ(25 mg/kg,i.p.),1周后随机血糖≥11.1 mmol/L为DM模型构建成功,常规制备MI/R(30 min/4 h)模型。将大鼠随机分为4组:假手术组、MI/R组、DM+假手术组、DM+MI/R组。多导生理记录仪检测左室压上升/下降最大速率(±LVdP/dtmax),Evans blue-TTC双染色法检测心肌梗死面积,TUNEL法进行心肌细胞凋亡测试、试剂盒检测caspase-3活性,Western blot检测GRP78、Chop和PKG等蛋白表达。结果 与对照组相比,DM大鼠MI/R心肌损伤加重。VNP治疗(再灌前10 min,给予100 μg/kg,i.v)可显著减轻DM大鼠MI/R损伤,包括增强±LVdP/dtmax,降低心梗范围、死亡率与Caspase-3活性(n=8,P<0.05)。此外,VNP可降低内质网应激相关蛋白GRP78、CHOP表达(n=3,P<0.01)。VNP上述效应可同时被PKG阻断剂KT-5823(再灌前20 min,给予0.5 mg/kg,i.p)抑制、并被cGMP衍生物8-Br-cGMP(1 mg/kg)模拟(P<0.05,P<0.01)。用内质网应激抑制剂TUDCA(50 mg/kg)预处理DM大鼠,并不能增强VNP的心肌保护作用。结论 VNP治疗可减轻DM性MI/R损伤,其机制可能与通过cGMP-PKG信号抑制内质网应激有关,提示VNP对DM性缺血性心脏病具有潜在治疗价值。
Abstract:
AIM To investigate the effects of vasonatrin peptide (VNP) on myocardial ischemia/reperfusion (MI/R) injury in diabetic rats and to elucidate its mechanisms. METHODSHigh-fat diet and low-dose streptozotocin (STZ, 25 mg/kg, i.p.) injection induced diabetic Sprague Dawley rats with random blood glucose level >11.1 mmol/L 1 week later. Left anterior descending coronary artery was ligated for 30 min and reperfused for 4 h to establish the in vivo model of ischemia-reperfusion. RESULTSVNP treatment (100 μg/kg, i.v., 10 min before R) significantly improved ±LV dP/dtmax and LVSP and reduced LVEDP, apoptosis index, caspase-3 activity, plasma CK and LDH activities. Moreover, VNP inhibited endoplasmic reticulum (ER) stress by suppressing GRP78 and CHOP. These effects were mimicked by 8-Br-cGMP, a cGMP analogue but were inhibited by KT-5823, a selective inhibitor of PKG. In addition, pretreatment of DM rats with TUDCA, a specific inhibitor of ER stress, did not further promote the cardioprotective effect of VNP. CONCLUSIONVNP protects diabetic heart against MI/R injury by inhibiting ER stress via cGMP-PKG signaling pathway. These results suggest that VNP may have some potential therapeutic value for diabetic patients with ischemic heart disease.

参考文献/References

[1]Thom T,Haase N,Rosamond W,et al.Heart disease and stroke statistics--2006 update:a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee[J].Circulation,2006,113(6):e85-e151.
[2]Lee,MG,Jeong MH,Ahn Y,et al.Comparison of clinical outcomes following acute myocardial infarctions in hypertensive patients with or without diabetes[J].Korean Circ J,2009,39(6):243-250.
[3]Bravo,R,Parra V,Gatica D,et al.Endoplasmic reticulum and the unfolded protein response:dynamics and metabolic integration[J].Int Rev Cell Mol Biol,2013,301:215-290.
[4]Toth A,Nickson P,Mandl A,et al.Endoplasmic reticulum stress as a novel therapeutic target in heart diseases[J].Cardiovasc Hematol Disord Drug Targets,2007,7(3):205-218.
[5]Xu J,Zhou Q,Xu W,et al.Endoplasmic reticulum stress and diabetic cardiomyopathy[J].Exp Diabetes Res,2012,2012:827971.
[6]Moro C,Lafontan M.Natriuretic peptides and cGMP signaling control of energy homeostasis[J].Am J Physiol Heart Circ Physiol,2013,304(3):H358- H368.
[7]Fujii Y,Ishino K,Tomii T,et al.Atrionatriuretic peptide improves left ventricular function after myocardial global ischemia-reperfusion in hypoxic hearts[J].Artif Organs,2012,36(4):379-386.
[8]Guo HT,Zhu MZ,Lu SY,et al.Vasonatrin peptide attenuates hypoxia-induced increase in[Ca(2+)](i)of culured rat cardiac fibroblasts[J].Sheng Li Xue Bao,2001,53(4):286-290.
[9]Watts LM,Manchem VP,Leedom TA,et al.Reduction of hepatic and adipose tissue glucocorticoid receptor expression with antisense oligonucleotides improves hyperglycemia and hyperlipidemia in diabetic rodents without causing systemic glucocorticoid antagonism[J].Diabetes,2005,54(6):1846-1853.
[10]Apaijai N,Pintana H,Chattipakorn SC,et al.Effects of vildagliptin vs.sitagliptin,on cardiac function,heart rate variability,and mitochondrial function in obese insulin resistant rats[J].Br J Pharmacol,2013,169(5):1048-1057.
[11]Yan W,Zhang H,Liu P,et al.Impaired mitochondrial biogenesis due to dysfunctional adiponectin-AMPK-PGC-1alpha signaling contributing to increased vulnerability in diabetic heart[J].Basic Res Cardiol,2013,108(3):329.
[12]Ding W,Yang L,Zhang M,et al.Reactive oxygen species-mediated endoplasmic reticulum stress contributes to aldosterone-induced apoptosis in tubular epithelial cells[J].Biochem Biophys Res Commun,2012,418(3):451-456.
[13]Duda T.Atrial natriuretic factor-receptor guanylate cyclase signal transduction mechanism[J].Mol Cell Biochem,2010,334(1-2):37-51.
[14]Smolenski A,Poller W,Walter U,et al.Regulation of human endothelial cell focal adhesion sites and migration by cGMP-dependent protein kinase I[J].J Biol Chem,2000,275(33):25723-25732.
[15]Salloum FN,Chau VQ,Hoke NN,et al.Phosphodiesterase-5 inhibitor,tadalafil,protects against myocardial ischemia/reperfusion through protein-kinase g-dependent generation of hydrogen sulfide[J].Circulation,2009,120(11 Suppl):S31-S36.
[16]ZhangY,Xia Z,La Cour KH,et al.Activation of Akt rescues endoplasmic reticulum stress-impaired murine cardiac contractile function via glycogen synthase kinase-3beta-mediated suppression of mitochondrial permeation pore opening[J].Antioxid Redox Signal,2011,15(9):2407-2424.

备注/Memo

备注/Memo:
收稿日期:2015-10-27.
基金项目:国家自然科学基金项目资助(81270330,31271220,81300190和81300077);陕西省社会发展科技攻关项目资助(2014K11-02-03-02)
通讯作者:张海锋,副教授,主要从事心脏保护方面研究Email:hfzhang@fmmu.edu.cn
共同通讯作者:朱妙章,教授,主要从事钠尿肽方面研究Email:mz_zhu@fmmu.edu.cn
作者简介:梁向艳,实验师,硕士Email:liangxiangyan@126.com
更新日期/Last Update: 2016-07-10